Introduction Although the hallmark feature of essential tremor (ET) is tremor, there is growing
appreciation that cognitive impairment also occurs, including increased prevalence of mild …

Insulin-like growth factor-1 (IGF-1) function declines with age and is associated with brain
ageing and the progression of age-related neurological conditions. The reversible binding of …

Introduction Identification of factors associated with progression of cognitive symptoms in
Parkinson's disease (PD) is important for treatment planning, clinical care, and design of …

Background: This study was conducted to evaluate the effects of probiotic supplementation
on gene expression related to inflammation, insulin and lipid in patients with Parkinson's …

Background Growing evidence suggests an association between imaging biomarkers of
small vessel disease and future cognitive decline in Parkinson's disease (PD). Recently …

Background: Genetic, biologic and clinical data suggest that Parkinson's disease (PD) is an
umbrella for multiple disorders with clinical and pathological overlap, yet with different …

Background and purpose Dementia in Parkinson's disease (PD) is common and disabling.
Identification of modifiable risk factors for it is essential. Vascular risk factors (VRFs) may be …

Parkinson's disease (PD) is the second most common neurodegenerative disease
characterised by both motor-and non-motor symptoms, including cognitive impairment. The …

Evidence shows that metabolic syndrome (MS) is associated with a greater risk of
developing Parkinson's disease (PD) because of the increase in oxidative stress levels …

Dementia in advanced Parkinson's Disease (PD) is a fatal milestone resulting in reduced life
expectancy and nursing home placement. Cognitive impairment and cardiovascular …